APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174027350322 December 2025192 pages

Choose your research edition.

Industry ResearchPorcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines include CAHIC, Agrovet, Bioveta, Boehringer Ingelheim, CAVAC, Ceva, DHN, Komipharm and MSD Animal Health, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.

Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Segment by Company

CAHIC

Agrovet

Bioveta

Boehringer Ingelheim

CAVAC

Ceva

DHN

Komipharm

MSD Animal Health

Phibro Animal Health

PULILE

Ringpu Biology

Tecon

WINSUN

ChengDu Tecbond

Sino Pharm

Jinyu Bio-Technology

Qilu Animal

Zoetis

Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Segment by Type

Live Vaccines

Killed Vaccines

Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Segment by Application

Government Tender

Market Sales

Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Trends Table 2. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Drivers Table 3. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Opportunities and Challenges Table 4. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Restraints Table 5. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Manufacturers (m units) & (2021-2026) Table 8. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Manufacturers Table 9. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Average Sales Price (US$/k unit) of Manufacturers (2021-2026) Table 10. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Manufacturers, Product Type & Application Table 13. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Live Vaccines Table 17. Major Manufacturers of Killed Vaccines Table 18. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type 2021 VS 2025 VS 2032 (m units) Table 19. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2021-2026) & (m units) Table 20. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2027-2032) & (m units) Table 21. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Type (2021-2026) Table 22. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Type (2027-2032) Table 23. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type 2021 VS 2025 VS 2032 (m units) Table 24. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type (2021-2026) & (m units) Table 25. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type (2027-2032) & (m units) Table 26. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Type (2021-2026) Table 27. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Government Tender Table 29. Major Manufacturers of Market Sales Table 30. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application 2021 VS 2025 VS 2032 (m units) Table 31. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2021-2026) & (m units) Table 32. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2027-2032) & (m units) Table 33. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Application (2021-2026) Table 34. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Application (2027-2032) Table 35. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application 2021 VS 2025 VS 2032 (m units) Table 36. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application (2021-2026) & (m units) Table 37. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application (2027-2032) & (m units) Table 38. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Application (2021-2026) Table 39. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Application (2027-2032) Table 40. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region: 2021 VS 2025 VS 2032 (m units) Table 41. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region (2021-2026) & (m units) Table 42. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Region (2021-2026) Table 43. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Forecasted by Region (2027-2032) & (m units) Table 44. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (m units) Table 46. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2021-2026) & (m units) Table 47. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2027-2032) & (m units) Table 48. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (m units) Table 49. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2021-2026) & (m units) Table 50. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2027-2032) & (m units) Table 51. Asia Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (m units) Table 52. Asia Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2021-2026) & (m units) Table 53. Asia Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2027-2032) & (m units) Table 54. South America, Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (m units) Table 55. South America, Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2021-2026) & (m units) Table 56. South America, Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2027-2032) & (m units) Table 57. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Region (2021-2026) Table 61. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Region (2027-2032) Table 62. CAHIC Company Information Table 63. CAHIC Business Overview Table 64. CAHIC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. CAHIC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 66. CAHIC Recent Development Table 67. Agrovet Company Information Table 68. Agrovet Business Overview Table 69. Agrovet Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Agrovet Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 71. Agrovet Recent Development Table 72. Bioveta Company Information Table 73. Bioveta Business Overview Table 74. Bioveta Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Bioveta Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 76. Bioveta Recent Development Table 77. Boehringer Ingelheim Company Information Table 78. Boehringer Ingelheim Business Overview Table 79. Boehringer Ingelheim Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Boehringer Ingelheim Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 81. Boehringer Ingelheim Recent Development Table 82. CAVAC Company Information Table 83. CAVAC Business Overview Table 84. CAVAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. CAVAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 86. CAVAC Recent Development Table 87. Ceva Company Information Table 88. Ceva Business Overview Table 89. Ceva Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Ceva Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 91. Ceva Recent Development Table 92. DHN Company Information Table 93. DHN Business Overview Table 94. DHN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. DHN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 96. DHN Recent Development Table 97. Komipharm Company Information Table 98. Komipharm Business Overview Table 99. Komipharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Komipharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 101. Komipharm Recent Development Table 102. MSD Animal Health Company Information Table 103. MSD Animal Health Business Overview Table 104. MSD Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. MSD Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 106. MSD Animal Health Recent Development Table 107. Phibro Animal Health Company Information Table 108. Phibro Animal Health Business Overview Table 109. Phibro Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Phibro Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 111. Phibro Animal Health Recent Development Table 112. PULILE Company Information Table 113. PULILE Business Overview Table 114. PULILE Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. PULILE Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 116. PULILE Recent Development Table 117. Ringpu Biology Company Information Table 118. Ringpu Biology Business Overview Table 119. Ringpu Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Ringpu Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 121. Ringpu Biology Recent Development Table 122. Tecon Company Information Table 123. Tecon Business Overview Table 124. Tecon Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. Tecon Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 126. Tecon Recent Development Table 127. WINSUN Company Information Table 128. WINSUN Business Overview Table 129. WINSUN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 130. WINSUN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 131. WINSUN Recent Development Table 132. ChengDu Tecbond Company Information Table 133. ChengDu Tecbond Business Overview Table 134. ChengDu Tecbond Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 135. ChengDu Tecbond Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 136. ChengDu Tecbond Recent Development Table 137. Sino Pharm Company Information Table 138. Sino Pharm Business Overview Table 139. Sino Pharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 140. Sino Pharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 141. Sino Pharm Recent Development Table 142. Jinyu Bio-Technology Company Information Table 143. Jinyu Bio-Technology Business Overview Table 144. Jinyu Bio-Technology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 145. Jinyu Bio-Technology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 146. Jinyu Bio-Technology Recent Development Table 147. Qilu Animal Company Information Table 148. Qilu Animal Business Overview Table 149. Qilu Animal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 150. Qilu Animal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 151. Qilu Animal Recent Development Table 152. Zoetis Company Information Table 153. Zoetis Business Overview Table 154. Zoetis Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 155. Zoetis Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio Table 156. Zoetis Recent Development Table 157. Key Raw Materials Table 158. Raw Materials Key Suppliers Table 159. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Distributors List Table 160. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Customers List Table 161. Research Programs/Design for This Report Table 162. Authors List of This Report Table 163. Secondary Sources Table 164. Primary Sources List of Figures Figure 1. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Image Figure 2. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (2021-2032) & (m units) Figure 5. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Average Price (US$/k unit) & (2021-2032) Figure 6. Global Top 5 and 10 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Live Vaccines Image Figure 9. Killed Vaccines Image Figure 10. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2021 VS 2025 VS 2032) & (m units) Figure 11. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Type (2021-2032) Figure 13. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (m units) Figure 14. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Type (2021-2032) Figure 16. Government Tender Image Figure 17. Market Sales Image Figure 18. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2021 VS 2025 VS 2032) & (m units) Figure 19. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Application (2021-2032) Figure 21. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (m units) Figure 22. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Application (2021-2032) Figure 24. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 25. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Country (2021-2032) Figure 26. U.S. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 27. Canada Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 28. Mexico Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 29. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 30. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Country (2021-2032) Figure 31. Germany Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 32. France Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 33. U.K. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 34. Italy Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 35. Netherlands Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 36. Asia Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 37. Asia Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Country (2021-2032) Figure 38. China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 39. Japan Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 40. South Korea Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 41. Southeast Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 42. India Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 43. Australia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 44. South America, Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 45. South America, Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Country (2021-2032) Figure 46. Brazil Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 47. South Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 48. Saudi Arabia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 49. Turkey Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 50. Argentina Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 51. UAE Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 52. Egypt Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 53. Chile Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 54. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue (2021-2032) & (US$ Million) Figure 57. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue (2021-2032) & (US$ Million) Figure 59. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Live Vaccines
  • Killed Vaccines
Applications
  • Government Tender
  • Market Sales
Companies covered
  • CAHIC
  • Agrovet
  • Bioveta
  • Boehringer Ingelheim
  • CAVAC
  • Ceva
  • DHN
  • Komipharm
  • MSD Animal Health
  • Phibro Animal Health
  • PULILE
  • Ringpu Biology
  • Tecon
  • WINSUN
  • ChengDu Tecbond
  • Sino Pharm
  • Jinyu Bio-Technology
  • Qilu Animal
  • Zoetis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Dynamics
  1. 2.1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Trends
  2. 2.2 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Drivers
  3. 2.3 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Opportunities and Challenges
  4. 2.4 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Restraints
3 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market by Manufacturers
  1. 3.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Manufacturers (2021-2026)
  3. 3.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Manufacturers, Product Type & Application
  7. 3.7 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Tier 1, Tier 2, and Tier 3
4 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market by Type
  1. 4.1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Type Introduction
  2. 4.1.1 Live Vaccines
  3. 4.1.2 Killed Vaccines
  4. 4.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type
  5. 4.2.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2021-2032)
  7. 4.2.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Type (2021-2032)
  8. 4.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type
  9. 4.3.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type (2021-2032)
  11. 4.3.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Type (2021-2032)
5 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market by Application
  1. 5.1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Application Introduction
  2. 5.1.1 Government Tender
  3. 5.1.2 Market Sales
  4. 5.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application
  5. 5.2.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2021-2032)
  7. 5.2.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Application (2021-2032)
  8. 5.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application
  9. 5.3.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application (2021-2032)
  11. 5.3.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Application (2021-2032)
6 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region
  1. 6.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region (2021-2032)
  3. 6.2.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region (2021-2026)
  4. 6.2.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Region
  1. 7.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Region
  2. 7.1.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Region (2021-2026)
  4. 7.1.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Region (2027-2032)
  5. 7.1.4 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue (2021-2032)
  8. 7.2.2 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue (2021-2032)
  11. 7.3.2 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 CAHIC
  2. 8.1.1 CAHIC Company Information
  3. 8.1.2 CAHIC Business Overview
  4. 8.1.3 CAHIC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 CAHIC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  6. 8.1.5 CAHIC Recent Developments
  7. 8.2 Agrovet
  8. 8.2.1 Agrovet Company Information
  9. 8.2.2 Agrovet Business Overview
  10. 8.2.3 Agrovet Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Agrovet Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  12. 8.2.5 Agrovet Recent Developments
  13. 8.3 Bioveta
  14. 8.3.1 Bioveta Company Information
  15. 8.3.2 Bioveta Business Overview
  16. 8.3.3 Bioveta Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Bioveta Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  18. 8.3.5 Bioveta Recent Developments
  19. 8.4 Boehringer Ingelheim
  20. 8.4.1 Boehringer Ingelheim Company Information
  21. 8.4.2 Boehringer Ingelheim Business Overview
  22. 8.4.3 Boehringer Ingelheim Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Boehringer Ingelheim Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  24. 8.4.5 Boehringer Ingelheim Recent Developments
  25. 8.5 CAVAC
  26. 8.5.1 CAVAC Company Information
  27. 8.5.2 CAVAC Business Overview
  28. 8.5.3 CAVAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 CAVAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  30. 8.5.5 CAVAC Recent Developments
  31. 8.6 Ceva
  32. 8.6.1 Ceva Company Information
  33. 8.6.2 Ceva Business Overview
  34. 8.6.3 Ceva Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Ceva Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  36. 8.6.5 Ceva Recent Developments
  37. 8.7 DHN
  38. 8.7.1 DHN Company Information
  39. 8.7.2 DHN Business Overview
  40. 8.7.3 DHN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 DHN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  42. 8.7.5 DHN Recent Developments
  43. 8.8 Komipharm
  44. 8.8.1 Komipharm Company Information
  45. 8.8.2 Komipharm Business Overview
  46. 8.8.3 Komipharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Komipharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  48. 8.8.5 Komipharm Recent Developments
  49. 8.9 MSD Animal Health
  50. 8.9.1 MSD Animal Health Company Information
  51. 8.9.2 MSD Animal Health Business Overview
  52. 8.9.3 MSD Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 MSD Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  54. 8.9.5 MSD Animal Health Recent Developments
  55. 8.10 Phibro Animal Health
  56. 8.10.1 Phibro Animal Health Company Information
  57. 8.10.2 Phibro Animal Health Business Overview
  58. 8.10.3 Phibro Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Phibro Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  60. 8.10.5 Phibro Animal Health Recent Developments
  61. 8.11 PULILE
  62. 8.11.1 PULILE Company Information
  63. 8.11.2 PULILE Business Overview
  64. 8.11.3 PULILE Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 PULILE Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  66. 8.11.5 PULILE Recent Developments
  67. 8.12 Ringpu Biology
  68. 8.12.1 Ringpu Biology Company Information
  69. 8.12.2 Ringpu Biology Business Overview
  70. 8.12.3 Ringpu Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Ringpu Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  72. 8.12.5 Ringpu Biology Recent Developments
  73. 8.13 Tecon
  74. 8.13.1 Tecon Company Information
  75. 8.13.2 Tecon Business Overview
  76. 8.13.3 Tecon Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Tecon Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  78. 8.13.5 Tecon Recent Developments
  79. 8.14 WINSUN
  80. 8.14.1 WINSUN Company Information
  81. 8.14.2 WINSUN Business Overview
  82. 8.14.3 WINSUN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 WINSUN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  84. 8.14.5 WINSUN Recent Developments
  85. 8.15 ChengDu Tecbond
  86. 8.15.1 ChengDu Tecbond Company Information
  87. 8.15.2 ChengDu Tecbond Business Overview
  88. 8.15.3 ChengDu Tecbond Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 ChengDu Tecbond Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  90. 8.15.5 ChengDu Tecbond Recent Developments
  91. 8.16 Sino Pharm
  92. 8.16.1 Sino Pharm Company Information
  93. 8.16.2 Sino Pharm Business Overview
  94. 8.16.3 Sino Pharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Sino Pharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  96. 8.16.5 Sino Pharm Recent Developments
  97. 8.17 Jinyu Bio-Technology
  98. 8.17.1 Jinyu Bio-Technology Company Information
  99. 8.17.2 Jinyu Bio-Technology Business Overview
  100. 8.17.3 Jinyu Bio-Technology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Jinyu Bio-Technology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  102. 8.17.5 Jinyu Bio-Technology Recent Developments
  103. 8.18 Qilu Animal
  104. 8.18.1 Qilu Animal Company Information
  105. 8.18.2 Qilu Animal Business Overview
  106. 8.18.3 Qilu Animal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Qilu Animal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  108. 8.18.5 Qilu Animal Recent Developments
  109. 8.19 Zoetis
  110. 8.19.1 Zoetis Company Information
  111. 8.19.2 Zoetis Business Overview
  112. 8.19.3 Zoetis Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Zoetis Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
  114. 8.19.5 Zoetis Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Value Chain Analysis
  2. 9.1.1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Production Mode & Process
  6. 9.2 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Distributors
  9. 9.2.3 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst